中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2014年
24期
41-42
,共2页
阿卡波糖片%2型糖尿病%二甲双胍肠溶胶囊
阿卡波糖片%2型糖尿病%二甲雙胍腸溶膠囊
아잡파당편%2형당뇨병%이갑쌍고장용효낭
Acarbose%Type 2 diabetes mellitus%Metformin enteric coated capsules
目的：观察单独使用阿卡波糖片对初治糖化血红蛋白(HbA1c)＜8.5%的2型糖尿病(T2DM)患者血糖水平的控制效果。方法：对单独使用阿卡波糖片或二甲双胍肠溶胶囊的T2DM患者治疗前及治疗后6个月的血糖、HbA1c、血脂、体质量指数(BMI)的变化进行比较。结果：两种药物单独使用均可使T2DM患者血糖、HbA1c下降，差异均有统计学意义(P＜0.05)。两药之间比较差异无统计学意义(P＞0.05)。结论：阿卡波糖片能有效控制T2DM患者血糖及HbA1c水平。
目的：觀察單獨使用阿卡波糖片對初治糖化血紅蛋白(HbA1c)＜8.5%的2型糖尿病(T2DM)患者血糖水平的控製效果。方法：對單獨使用阿卡波糖片或二甲雙胍腸溶膠囊的T2DM患者治療前及治療後6箇月的血糖、HbA1c、血脂、體質量指數(BMI)的變化進行比較。結果：兩種藥物單獨使用均可使T2DM患者血糖、HbA1c下降，差異均有統計學意義(P＜0.05)。兩藥之間比較差異無統計學意義(P＞0.05)。結論：阿卡波糖片能有效控製T2DM患者血糖及HbA1c水平。
목적：관찰단독사용아잡파당편대초치당화혈홍단백(HbA1c)＜8.5%적2형당뇨병(T2DM)환자혈당수평적공제효과。방법：대단독사용아잡파당편혹이갑쌍고장용효낭적T2DM환자치료전급치료후6개월적혈당、HbA1c、혈지、체질량지수(BMI)적변화진행비교。결과：량충약물단독사용균가사T2DM환자혈당、HbA1c하강，차이균유통계학의의(P＜0.05)。량약지간비교차이무통계학의의(P＞0.05)。결론：아잡파당편능유효공제T2DM환자혈당급HbA1c수평。
Objective:To observe the blood glucose level control of the separate use of acarbose in the treatment of primary glycosylated hemoglobin(HbA1c)<8.5% in patients with type 2 diabetes mellitus(T2DM).Methods:We compared the changes of blood lipid, blood glucose, HbA1c, body mass index(BMI) of T2DM patients who use the acarbose or metformin enteric coated capsules separately before and after the treatment 6 months.Results:The two kinds of drug used alone can make the blood glucose and HbA1c decreased in T2DM patients,and there were significant differences(P<O.05).There was no significant difference between the two drugs (P>O.05).Conclusion:The acarbose can effectively control blood glucose and HbA1c levels in patients with T2DM.
